| Trial registration number
|
IRCT20220302054167N1 |
Full text link
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/62333
|
First author
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
DR. Mhamad Khazaii
|
Contact
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
it.amoozesh@umsha.ac.ir
|
Registration date
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2022-04-29
|
Recruitment status
Last imported at : May 9, 2022, 6 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Open label
|
Center
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Outpatients with Covid-19 symptoms after positive Covid-19 RT-PCR test
Oxygen level 98-92%
|
Exclusion criteria
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
• Dissatisfaction of the patient or their relatives to participate in the study
• Pregnancy and lactation
Evidence of pulmonary involvement and the need for hospitalization or referral to an infectious disease specialist
Prohibition of N-acetylcysteine and bromhexine as a history of allergy and anaphylactic shock
|
Number of arms
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Hamedan University of Medical Sciences
|
Inclusion age min
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
70
|
Countries
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mild disease at enrollment
|
Severity scale
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
1: Mild disease at enrollment
|
Total sample size
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
92
|
primary outcome
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
blood Oxygen
Cough
Shortness of breath
Sore throat
|
Notes
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : April 30, 2022, 4 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 18, "treatment_name": "Acetylcysteine", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 239, "treatment_name": "Bromhexine", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}]
|